Purpose Severe acute respiratory syndrome coronavirus 2 is the virus resulting in COVID-19
infections in nearly 4.3 million Americans with COVID-19 in the United States as of July 29 …

We read with interest the article entitled “Neurological manifestations of coronavirus disease
2019: exploring past to understand present”[1] that reported neurological manifestations at …

Abstract Purpose of Review Since the beginning of the coronavirus disease 2019 pandemic,
many lasting neurological sequelae including cognitive impairment have been recognized …

Abstract The coronavirus (COVID-19) pandemic is still evolving, causing hundreds of
millions of infections around the world. The long-term sequelae of COVID-19 and neurologic …

Severe acute respiratory syndrome coronavirus 2 is a worldwide public health issue. Almost
2 years into the pandemic, the persistence of symptoms after the acute phase is a well …

Objective: To date, very few studies investigating neurocognitive deficits in COVID-19 have
been published. This case series addresses cognition in post-COVID-19 patient by …

Neurocognitive and psychiatric post-COVID-19 long-term conditions are frequent and
complex multifactorial sequelae. Several acute and chronic factors such as hypoxemia …

Background There is a limited understanding of the cognitive and psychiatric sequelae of
COVID-19 during the post-acute phase, particularly among racially and ethnically diverse …

COVID-19, caused by the SARS-CoV-2 virus, is a respiratory infectious disease. While most
patients recover after treatment, there is growing evidence that COVID-19 may result in …

As cases of coronavirus disease 2019 (COVID-19) mount worldwide, attention is needed on
potential long-term neurologic impacts for the majority of patients who experience mild to …